Related Experiment Video
Updated: May 30, 2025
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
Multi-level Factors to Build Confidence and Support in Active Surveillance for Low-Risk Prostate Cancer: A
Jason C Chen1,2, Lalita Subramanian3, Ted A Skolarus4
1Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. jasonchn@med.umich.edu.
Journal of General Internal Medicine
|January 27, 2025
Summary
Active surveillance for low-risk prostate cancer requires adherence to follow-up testing. Improving adherence involves enhancing patient confidence, providing psychosocial support, and optimizing healthcare systems.
Area of Science:
- Urology
- Oncology
- Healthcare Management
Background:
- Active surveillance (AS) is a guideline-recommended approach for low-risk prostate cancer.
- Adherence to AS, including follow-up testing and remaining on surveillance, presents challenges.
Purpose of the Study:
- To understand provider and patient experiences with AS care delivery.
- To identify opportunities for improving adherence to active surveillance.
Main Methods:
- Qualitative study involving 19 PCPs, 15 urologists, and 15 patients with AS experience.
- Semi-structured interviews guided by the Theoretical Domains Framework and Behavior Change Wheel.
- Thematic analysis to identify shared perspectives on AS care delivery.
Main Results:
- Building patient confidence in AS through provider expertise and communication.
- Enhancing AS confidence via psychosocial support, including family and peer involvement.
- Integrating AS support within healthcare processes and electronic health records.
Conclusions:
- Interventions are needed at care team, community, and health system levels.
- Team-based approaches can improve individualized care and AS adherence.
- Addressing challenges in AS care delivery is crucial for patient outcomes.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
324
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
324
02:20Longitudinal Research
11.8K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.8K
01:30Cancer Vaccines
330
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
330